Transcription
A 3.6 kb transcript is detected preferentially in lymphohematopoietic tissues and certain cancer cells. Two alternatively spliced variants encoding the same isoform have been characterized to date.
Protein

Description
The SIPA1 protein, SPA-1, contains 1042 amino-acids (130 KDa); contains Rap GTPase-activating (GAP) domain , and leucine zipper like domain (964-1042) which resembles myosin tail.
Expression
SPA-1 is most abundantly expressed in lymphohematopoietic tissues including bone marrow, thymus and spleen.
Localisation
Localized in various intracellular compartments, such as actin cytoskeleton, plasma membranes, and possibly nuclei, depending on the cell type and specific protein interaction via the PDZ domain.
Function
SPA-1 exhibits a specific GAP activity for Ras-related regulatory proteins Rap1 and Rap2, but not for Ran or other small GTPases. SPA-1 overexpression (abrogating the endogenous Rap1 activation) induced rounding and eventual detachment of inherently adherent cells from extra-cellular matrix, indicating that Rap1 signals are involved in the regulation of cell adhesion and SPA-1 functions as a negative regulator of cell adhesion.
Homology
SPA-1 is highly homologous to human rap1GAPs (RapGA1, RapGA2) at a catalytic domain called the GAP-related domain (GRD) (43% identical amino acids). So far, three homologous molecules of SPA-1 except human rap1GAPs have been reported; SPA-1-like (SPA-L1) (also called E6TP1 or SPAR), SPA-L2, and SPA-L3, all of which share a PDZ domain in addition to a GRD.
Mutations
Note SPA-1-deficient (Spa-1 -/-) mice also develop agedependent progression of T-cell unresponsiveness, preceding the overt development of leukemia described as follows. -/-mice show a progressive increase in their B1 cell populations in the peritoneal cavity as they aged; this was associated with the generation of anti-dsDNA antibody and lupus-like glomeluronephritis. Many of the Spa-1 -/-mice with B1 cell-type leukemia also show a hemolytic autoantibody; this feature highly resembled human B cell chronic lymphocytic leukemia (CLL). Sipa1 is a candidate gene for the Mtes-1 locus which is involved in controlling lung metastasis of mammary tumors in mouse model. In mice, there is a nonsynonymous polymorphism in the Sipa1, either alanine (A) or threonine (T) at the amino acid position 741 in the PDZ domain; all the strains with a Sipa1/741A allele showed high metastatic tendency, whereas those with a Sipa1/741T allele reveal less lung metastasis. Sipa1/741A shows higher Rap1GAP activity than Sipa1/741T in cancer cells, probably due to the altered binding affinity of the PDZ domain for the interacting proteins. In agreement, overexpression of wild type Sipa1 in mammary tumor cells markedly enhanced the lung metastatic activity, whereas knockdown of the endogenous Sipa1 reduces the activity. No pathological mutations have been detected in any leukemia cases.
Implicated in
Breast cancer
Note Several studies have shown that germline polymorphisms in SIPA1 are associated with metastasis of breast cancer (Crawford et al., 2006; ). Crawford et al. examined three SNPs within SIPA1 (one within the promoter (-313G>A: rs931127) and two exonic (545C>T: rs3741378 and 2760G>A: rs746429)). The population (n=300) consisted of randomly selected non-Hispanic Caucasian breast cancer patients using SNP-specfic PCR. They showed that the variant 2760G>A and the -313G>A allele were associated with lymp node involvement (P=0.0062 and P=0.0083, respectively), and the variant 545C>T was associated with estrogen receptor negative tumors (P=0.0012) and with progesterone negative tumors (P=0.0339). Associations were identified between haplotypes defined by the three SNPs and disease progression. Correlation of SIPA1 SNP rs3741378 with breast cancer susceptibility was also confirmed by Hsieh et al. 
